SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C33 - Non-Alzheimer's Dementia I: Frontotemporal Dementias and Chronic Traumatic Encephalopathy

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): Gil Rabinovici MD
Description: Frontotemporal dementia (FTD) and chronic traumatic encephalopathy (CTE) represent important, likely underdiagnosed, causes of neurodegenerative dementia. FTD is as common as Alzheimer's disease (AD) in patients presenting with an early-onset dementia (under age 65), whereas CTE is increasingly recognized through autopsy in individuals exposed to repetitive mild traumatic brain injury (through contact sports, military exposures, and other high-risk endeavors) who present with neurobehavioral decline. Faculty will present a case-based approach to introduce the diverse clinical presentations of these disorders, and provide an update on biomarker development and advances in understanding the genetic and molecular underpinnings of these disorders. This program complements C51: Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias, but covers independent topics.
Completion Message: Participants should be able to apply up-to-date clinical criteria and diagnostic tools to classify the different subtypes of FTD, to identify individuals at risk for CTE, and to differentiate FTD and CTE from AD. Improving clinical diagnosis and in vivo prediction of molecular pathology is critical in preparation for emerging disease-specific therapies for these disorders.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:45 PM Frontotemporal Dementia and Primary Progressive Aphasia Gil Dan Rabinovici MD 
1:45 PM - 2:00 PM Questions and Answers Faculty 
2:00 PM - 2:45 PM Chronic Traumatic Encephalopathy Andrew E. Budson MD 
2:45 PM - 3:00 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
Andrew E. Budson, MD Dr. Budson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lilly and Axovant.

Gil Dan Rabinovici, MD Dr. Rabinovici has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech and Merck. Dr. Rabinovici has received personal compensation in an editorial capacity for JAMA Neurology. Dr. Rabinovici has received research support from Avid Radiopharmaceuticals, Eli Lilly, GE Healthcare, and Piramal.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C1 Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
9:30 AM-11:30 AM
C13 Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C10 More than Medicine: How to Access Home Care, Support Caregivers, and Discuss Complex Situations in Advanced Neurologic Disease Farrah Daly MD, MBA
1:30 PM-3:30 PM
C20 The Neurology of Social Behavior Bradford Dickerson MD

Sunday April 22, 2018

7:00 AM-9:00 AM
C33 Clinicopathological Correlation Session in Dementia David Irwin MD
1:00 PM-3:00 PM
S2 Aging and Dementia Platform Session

Friday April 27, 2018

7:00 AM-9:00 AM
C219 The Early-Onset Dementias Mario Mendez MD, PhD, FAAN
12:00 PM-12:45 PM
Outsmart Stress Marie Pasinski MD
1:00 PM-3:00 PM
C227 Behavioral Neurology: A Case-based Approach A. Barrett MD, FAAN
S48 Aging and Dementia Platform Session
3:30 PM-5:30 PM
C238 Memory Disorders: A Case-based Approach David Wolk MD

MEMBER LOG IN

Forgot Password?